The elimination of herpes simplex plaques by antibody and the emergence of resistant strains
Pavan, P.R.; Ennis, F.A.
Journal of Immunology 118(6): 2167-2175
1977
ISSN/ISBN: 0022-1767 PMID: 193992 Document Number: 110453
Established type 1 HSV cells for several days to have a maximum effect. It did not prevent the production of viral induced antigens in a cell when applied after the cell was infected but did prevent the transmission of infection to contiguous cells. Strains which were resistant to elimination by antibody formed syncytia did not grow to significantly higher titers than nonresistant strains, and were as easily neutralized by antiserum as nonresistant strains.
Document emailed within 1 workday
Related Documents
Paludan, Søren.R.; Melchjorsen, J.; Malmgaard, L.; Mogensen, Søren.C. 2002: Expression of genes for cytokines and cytokine-related functions in leukocytes infected with Herpes simplex virus: comparison between resistant and susceptible mouse strains European Cytokine Network 13(3): 306-316Hinokuma, R. 1979: The effect of collagenase inhibitor in herpes simplex keratitis. Part I. the diagnosis of herpes simplex disciformis keratitis by fluorescent antibody technique Nippon Ganka Gakkai Zasshi 83(6): 507-512
Suzuki, T.; Fujita, K.; Nagamachi, Y.; Okubo, T. 1994: Emergence of arbekacin resistant strains among methicillin-resistant Staphylococcus aureus Japanese Journal of Antibiotics 47(6): 634-639
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Kruglova, A.I.; Nikolaeva, N.P.; Niukhalova, I.V.; Barinskiĭ, I.F.; Alimbarova, L.M.; Demkin, V.V. 2004: Polymorphism of herpes simplex virus type 1 and 2 DNA from laboratory strains and clinical material from patient with genital herpes Voprosy Virusologii 49(1): 23-27
Biesiadecka, A. 2000: Immunogenic activity of temperature sensitive mutation of herpes simplex virus type-1 in mono- and polyvalent conditions with different attenuated strains of virus. I. Analysis of humoral immunity induced by mutant temperature sensitive herpes simplex virus type-1 in monovalent systems Medycyna Doswiadczalna i Mikrobiologia 52(1): 81-88
Rossi, G. 1996: The re-emergence of tuberculosis: the endemia of multiple-antibiotic-resistant strains Recenti Progressi in Medicina 87(10): 487-488
Corbellini, S.; Caccuri, F.; Gelmi, M.; De Francesco, M.A.; Fiorentini, S.; Caruso, A.; Giagulli, C. 2014: Emergence of carbapenem-resistant Klebsiella Pneumoniae strains producing KPC-3 in Brescia Hospital, Italy New Microbiologica 37(2): 177-183
Baumann, R.; Wunderli, W.; Riess, C.; Vogt, M. 1993: Acyclovir-resistant Herpes simplex viruses in HIV-infected patients Schweizerische Medizinische Wochenschrift 123(51-52): 2394-2400
Senkevich, T.G.; Gibadulin, R.A.; Ugriumov, E.P.; Posevaia, T.A.; Barinskiĭ, I.F. 1982: Typing of herpes simplex virus strains by analyzing the viral DNA using restriction endonucleases Voprosy Virusologii 27(3): 330-334
Kirchner, H.; Kochen, M.; Munk, K.; Hirt, H.M.; Mergenhagen, S.E.; Rosenstreich, D.L. 1978: Differences in susceptibility to herpes simplex virus infection of inbred strains of mice Iarc Scientific Publications 1978(24 Part 2): 783-788
Eis-Hübinger, A.Maria.; Nyankiye, E.; Bitoungui, D.Mboua.; Ndjomou, J. 2002: Prevalence of herpes simplex virus type 2 antibody in Cameroon Sexually Transmitted Diseases 29(11): 637-642
Maeglin, B. 1987: Herpes simplex. Oral and peroral infection with Herpes simplex virus Schweizer Monatsschrift für Zahnmedizin 97(12): 1532-1536
Rimon, R.; Halonen, P.; Anttinen, E.; Evola, K. 1971: Complement fixing antibody to herpes simplex virus in patients with psychotic depression Diseases of the Nervous System 32(12): 822-824
Wasserman, N.; Ito, M.; Barron, A.L.; Reisman, R.E.; Arbesman, C.E. 1975: Herpes simplex virus in patients with sarcoidosis; lymphocyte transformation in vitro and antibody response New York State Journal of Medicine 75(6): 850-853
Cowan, F.M.; Johnson, A.M.; Ashley, R.; Corey, L.; Mindel, A. 1994: Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations Bmj 309(6965): 1325-1329
Smith, J.W.; Glorioso, J.C. 1976: Effect of cross-immunization on monotypic antibody responses to herpes simplex virus types 1 and 2 Journal of Immunology 116(4): 898-903
Saito, H. 1983: Immunologic studies of herpes simplex keratitis. Characterization of immune spleen cells in herpes simplex keratitis in mice Nippon Ganka Gakkai Zasshi 87(11): 1010-1016
Fyfe, J.A.; McKee, S.A.; Keller, P.M. 1983: Altered thymidine-thymidylate kinases from strains of herpes simplex virus with modified drug sensitivities to acyclovir and (E)-5-(2-bromovinyl)-2'-deoxyuridine Molecular Pharmacology 24(2): 316-323